HRP20040071B1 - Upotreba il-18 inhibitora u poremeä†ajima preosjetljivosti - Google Patents

Upotreba il-18 inhibitora u poremeä†ajima preosjetljivosti

Info

Publication number
HRP20040071B1
HRP20040071B1 HRP20040071AA HRP20040071A HRP20040071B1 HR P20040071 B1 HRP20040071 B1 HR P20040071B1 HR P20040071A A HRP20040071A A HR P20040071AA HR P20040071 A HRP20040071 A HR P20040071A HR P20040071 B1 HRP20040071 B1 HR P20040071B1
Authority
HR
Croatia
Prior art keywords
inhibitors
hypersensitivity disorders
hypersensitivity
disorders
medicament
Prior art date
Application number
HRP20040071AA
Other languages
English (en)
Inventor
Yolande Chvatchko
Marie Kosco-Vilbois
Original Assignee
Laboratoires Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono Sa filed Critical Laboratoires Serono Sa
Publication of HRP20040071A2 publication Critical patent/HRP20040071A2/hr
Publication of HRP20040071B1 publication Critical patent/HRP20040071B1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Izum se odnosi na upotrebu inhibitora IL-18 u pripravi lijeka za liječenje i/ili sprečavanje poremećaja preosjetljivosti, pogotovo odgođenog tipa preosjetljivosti.
HRP20040071AA 2001-08-10 2004-01-23 Upotreba il-18 inhibitora u poremeä†ajima preosjetljivosti HRP20040071B1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01118811 2001-08-10
EP02100735 2002-06-20
PCT/EP2002/008591 WO2003013577A2 (en) 2001-08-10 2002-08-01 Use of il-18 inhibitors in hypersensitivity disorders

Publications (2)

Publication Number Publication Date
HRP20040071A2 HRP20040071A2 (en) 2004-10-31
HRP20040071B1 true HRP20040071B1 (hr) 2015-08-28

Family

ID=26076673

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20040071AA HRP20040071B1 (hr) 2001-08-10 2004-01-23 Upotreba il-18 inhibitora u poremeä†ajima preosjetljivosti

Country Status (27)

Country Link
US (1) US20040247598A1 (hr)
EP (1) EP1423138B1 (hr)
JP (1) JP4301942B2 (hr)
KR (1) KR20040030948A (hr)
CN (1) CN100500210C (hr)
AR (1) AR035274A1 (hr)
AU (1) AU2002331376B2 (hr)
BR (1) BRPI0211827B8 (hr)
CA (1) CA2456247C (hr)
CY (1) CY1116137T1 (hr)
DK (1) DK1423138T3 (hr)
EA (1) EA006745B1 (hr)
ES (1) ES2533253T3 (hr)
HK (1) HK1069780A1 (hr)
HR (1) HRP20040071B1 (hr)
HU (1) HU230377B1 (hr)
IL (2) IL160230A0 (hr)
ME (1) ME00547B (hr)
MX (1) MXPA04001230A (hr)
NO (1) NO335688B1 (hr)
PL (1) PL227130B1 (hr)
PT (1) PT1423138E (hr)
RS (1) RS52224B (hr)
SI (1) SI1423138T1 (hr)
UA (1) UA78516C2 (hr)
WO (1) WO2003013577A2 (hr)
ZA (1) ZA200400442B (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006003927A1 (ja) * 2004-06-30 2006-01-12 Atsuo Sekiyama 非炎症性ストレス応答の指標剤およびその利用
SI2267024T1 (sl) 2005-06-03 2012-09-28 Ares Trading Sa Proizvodnja rekombinantnega IL-18 vezavnega proteina
CA2610804C (en) 2005-06-10 2013-11-19 Ares Trading S.A. Process for the purification of il-18 binding protein
ES2514495T3 (es) 2006-05-25 2014-10-28 Glaxo Group Limited Anticuerpos humanizados modificados anti-interleucina-18
WO2012081650A1 (ja) * 2010-12-16 2012-06-21 株式会社明治 遅延型過敏症軽減剤

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0864585A1 (en) * 1997-03-12 1998-09-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
WO1999046248A1 (en) * 1998-03-09 1999-09-16 Vertex Pharmaceuticals Incorporated 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
EP0974600A2 (en) * 1998-06-24 2000-01-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Anti-interleukin-18 antibody
WO2000071719A1 (en) * 1999-05-20 2000-11-30 Hyseq, Inc. Interleukin-1 hy2 materials and methods
EP1110969A1 (en) * 1998-09-01 2001-06-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin 18-binding protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0864585A1 (en) * 1997-03-12 1998-09-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
WO1999046248A1 (en) * 1998-03-09 1999-09-16 Vertex Pharmaceuticals Incorporated 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
EP0974600A2 (en) * 1998-06-24 2000-01-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Anti-interleukin-18 antibody
EP1110969A1 (en) * 1998-09-01 2001-06-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin 18-binding protein
WO2000071719A1 (en) * 1999-05-20 2000-11-30 Hyseq, Inc. Interleukin-1 hy2 materials and methods

Also Published As

Publication number Publication date
WO2003013577A3 (en) 2003-09-25
NO335688B1 (no) 2015-01-19
US20040247598A1 (en) 2004-12-09
EP1423138B1 (en) 2014-12-24
BRPI0211827B8 (pt) 2021-05-25
CN1568193A (zh) 2005-01-19
PL227130B1 (pl) 2017-10-31
RS52224B (sr) 2012-10-31
CA2456247C (en) 2013-09-10
EA200400296A1 (ru) 2004-06-24
JP4301942B2 (ja) 2009-07-22
CY1116137T1 (el) 2017-02-08
BRPI0211827B1 (pt) 2019-07-23
NO20040370L (no) 2004-03-23
WO2003013577A2 (en) 2003-02-20
PT1423138E (pt) 2015-02-09
SI1423138T1 (sl) 2015-04-30
EP1423138A2 (en) 2004-06-02
BR0211827A (pt) 2004-08-31
DK1423138T3 (en) 2015-02-23
MXPA04001230A (es) 2004-05-27
AR035274A1 (es) 2004-05-05
HK1069780A1 (en) 2005-06-03
JP2005501080A (ja) 2005-01-13
PL368231A1 (en) 2005-03-21
CN100500210C (zh) 2009-06-17
HUP0401323A2 (hu) 2004-10-28
HRP20040071A2 (en) 2004-10-31
KR20040030948A (ko) 2004-04-09
ZA200400442B (en) 2005-03-30
AU2002331376B2 (en) 2007-06-14
ME00547B (me) 2011-12-20
UA78516C2 (en) 2007-04-10
IL160230A (en) 2014-11-30
EA006745B1 (ru) 2006-04-28
YU11904A (sh) 2006-08-17
CA2456247A1 (en) 2003-02-20
ES2533253T3 (es) 2015-04-08
HUP0401323A3 (en) 2006-01-30
IL160230A0 (en) 2004-07-25
HU230377B1 (hu) 2016-03-29

Similar Documents

Publication Publication Date Title
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
SE9703693D0 (sv) Novel combination
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
SE9802333D0 (sv) Novel combination
TR200502508T2 (tr) IL-18 İnhibitörlerinin kullanımı.
HRP20070552T3 (hr) Kombinacija antagoniste mglur2 i inhibitora ache za liječenje akutnih i/ili kroničnih neuroloških poremećaja
HUP0400202A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect, their use and pharmaceutical compositions containing them
MEP42808A (en) Use of flibanserin in the treatment of sexual disorders
DE60332433D1 (de) Azolylaminoazine als proteinkinasehemmer
PL375621A1 (en) Pharmaceutical compositions comprising flavonoids and menthol
IL172773A0 (en) Formulations for the treatment of arhritis conditions
IL158559A (en) Use of 5-lipoxygenase inhibitors for the preparation of a pharmaceutical composition for treating acne
BR0316170A (pt) Combinação, composição farmacêutica, uso de uma combinação, e, método para a profilaxia ou tratamento sinergìstico de câncer
BRPI0110506B8 (pt) uso de inibidores de il-18 para o tratamento e/ou prevenção da aterosclerose
IL160523A0 (en) PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
HRP20050579B1 (hr) Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
HUP0401854A2 (hu) COX-2 inhibitorokat és aszpirint tartalmazó kombinációk
ME00549B (me) Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
RS54140B1 (en) USE OF 24-ORDER
CY1116137T1 (el) Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας
HUP0401633A2 (hu) Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására
RS56006B1 (sr) Korišćenje inhibitora il-18 za lečenje ili prevenciju povreda cns
BR0111785A (pt) Composições e métodos para tratamento de candidìase
BR0210910A (pt) Derivados de imidazotriazinonas e sua aplicação contra processos inflamatórios e/ou doenças imunes
AU2002327970A1 (en) Inhibitors of costimulation by 0x40 and their use against infectious diseases

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: LABORATOIRES SERONO SA, CH

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190703

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200713

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210730

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20220801